WallStSmart

CME Group Inc (CME)vsFactSet Research Systems Inc (FDS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

CME Group Inc generates 181% more annual revenue ($6.74B vs $2.40B). CME leads profitability with a 63.3% profit margin vs 24.5%. FDS appears more attractively valued with a PEG of 1.14. FDS earns a higher WallStSmart Score of 65/100 (B-).

CME

Buy

65

out of 100

Grade: C+

Growth: 6.7Profit: 8.0Value: 4.3Quality: 5.0
Piotroski: 2/9Altman Z: 0.30

FDS

Strong Buy

65

out of 100

Grade: B-

Growth: 4.7Profit: 9.0Value: 6.3Quality: 6.0
Piotroski: 4/9Altman Z: 2.57

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CME6 strengths · Avg: 9.0/10
Profit MarginProfitability
63.3%10/10

Keeps 63 of every $100 in revenue as profit

Operating MarginProfitability
69.8%10/10

Strong operational efficiency at 69.8%

Market CapQuality
$90.52B9/10

Large-cap with strong market position

Debt/EquityHealth
0.139/10

Conservative balance sheet, low leverage

EPS GrowthGrowth
21.3%8/10

Earnings expanding 21.3% YoY

Free Cash FlowQuality
$1.24B8/10

Generating 1.2B in free cash flow

FDS4 strengths · Avg: 8.5/10
Return on EquityProfitability
27.6%9/10

Every $100 of equity generates 28 in profit

Profit MarginProfitability
24.5%9/10

Keeps 25 of every $100 in revenue as profit

P/E RatioValuation
15.5x8/10

Attractively priced relative to earnings

Operating MarginProfitability
29.8%8/10

Strong operational efficiency at 29.8%

Areas to Watch

CME3 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

PEG RatioValuation
4.522/10

Expensive relative to growth rate

Altman Z-ScoreHealth
0.302/10

Distress zone — elevated risk

FDS1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-4.5%2/10

Earnings declined 4.5%

Comparative Analysis Report

WallStSmart Research

Bull Case : CME

The strongest argument for CME centers on Profit Margin, Operating Margin, Market Cap. Profitability is solid with margins at 63.3% and operating margin at 69.8%. Revenue growth of 14.4% demonstrates continued momentum.

Bull Case : FDS

The strongest argument for FDS centers on Return on Equity, Profit Margin, P/E Ratio. Profitability is solid with margins at 24.5% and operating margin at 29.8%. PEG of 1.14 suggests the stock is reasonably priced for its growth.

Bear Case : CME

The primary concerns for CME are Piotroski F-Score, PEG Ratio, Altman Z-Score.

Bear Case : FDS

The primary concerns for FDS are EPS Growth.

Key Dynamics to Monitor

FDS carries more volatility with a beta of 0.71 — expect wider price swings.

CME is growing revenue faster at 14.4% — sustainability is the question.

CME generates stronger free cash flow (1.2B), providing more financial flexibility.

Monitor FINANCIAL DATA & STOCK EXCHANGES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CME scores higher overall (65/100 vs 65/100), backed by strong 63.3% margins and 14.4% revenue growth. Both earn "Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CME Group Inc

FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA

CME Group Inc. (Chicago Mercantile Exchange, Chicago Board of Trade, New York Mercantile Exchange, The Commodity Exchange) is an American global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, stock indexes and cryptocurrencies futures.

Visit Website →

FactSet Research Systems Inc

FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA

FactSet Research Systems Inc. provides integrated financial information and analytical applications to investment and corporate communities in the Americas, EMEA, and Asia Pacific. The company is headquartered in Norwalk, Connecticut.

Want to dig deeper into these stocks?